Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | LLY:NYQ since announced | Transaction value |
---|---|---|
Mablink Bioscience SAS | 40.43% | -- |
POINT Biopharma Global Inc | 60.87% | 1.38bn |
Data delayed at least 15 minutes, as of Jul 22 2024 21:10 BST.
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 31 Mar 2024 | 418.75k | 0.00% |
Western Asset Management Company DTVM Ltda.as of 31 Mar 2024 | 197.27k | 0.00% |
Banco J. Safra SAas of 31 Mar 2024 | 74.09k | 0.00% |
Bram Bradesco Asset Management S/A DTVMas of 31 Mar 2024 | 48.01k | 0.00% |
Safra Asset Management Ltda.as of 31 Mar 2024 | 23.10k | 0.00% |
Warren Brasil Gest�o e Administra��o e Recursos Ltda.as of 31 Mar 2024 | 9.63k | 0.00% |
BB Gest�o de Recursos DTVM SAas of 31 Mar 2024 | 4.00k | 0.00% |
XP Allocation Asset Management Ltda.as of 31 Mar 2024 | 1.38k | 0.00% |
BTG Pactual WM Gest�o de Recursos Ltda.as of 31 Mar 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 18 Jul 2024Source: FactSet Research Systems Inc.